Sejournet Lucas, Kodjikian Laurent, Mathis Thibaud, Comet Alban, Gascon Pierre, Matonti Frederic
Department of Ophthalmology, Hôpital de la Croix-Rousse, Hospices Civils de Lyon, 69004 Lyon, France.
Laboratoire MATEIS, UMR-CNRS 5510, INSA, Université Claude Bernard Lyon 1, 69100 Villeurbanne, France.
Pharmaceuticals (Basel). 2025 Jun 6;18(6):849. doi: 10.3390/ph18060849.
This retrospective observational study evaluates the efficacy and safety of a novel scleral fixation technique of the fluocinolone acetonide (FAc) implant in four consecutive patients with post-surgical macular edema (PSME). Four patients with PSME underwent intrascleral tunnel clamping (ITC) of the FAc implant due to lens defects. A 25-gauge sclerotomy was made 3.5 mm from the limbus and the implant was inserted into it until its end reached the edge of the sclera. Then, an 8-0 absorbable suture was passed through the sclera without penetrating the implant, thereby clamping the sclera around the FAc. All the patients showed improvements in best-corrected visual acuity (from a mean of 20/100 at baseline to 20/40) and central retinal thickness (from a mean of 534 µm at baseline to 318 µm) and with no recurrence of macular edema in most cases, without the need for further treatment. In addition, no anterior migration of the FAc implant or ocular hypertension was observed. This procedure effectively reduced the therapeutic burden for these patients. Although scleral fixation of the FAc implant has been described in small series of patients with successful results, this approach remains off-label. Although off-label, ITC of the FAc implant may offer a promising treatment option for patients who would otherwise remain untreated.
这项回顾性观察研究评估了一种新型的氟轻松醋酸酯(FAc)植入物巩膜固定技术在连续4例手术后黄斑水肿(PSME)患者中的疗效和安全性。4例PSME患者因晶状体缺陷接受了FAc植入物的巩膜内隧道夹闭术(ITC)。在距角膜缘3.5mm处做一个25G的巩膜切口,将植入物插入其中,直至其末端到达巩膜边缘。然后,一根8-0可吸收缝线穿过巩膜但不穿透植入物,从而在FAc周围夹闭巩膜。所有患者的最佳矫正视力均有改善(从基线时的平均20/100提高到20/40),中心视网膜厚度也有改善(从基线时的平均534µm降至318µm),且大多数情况下黄斑水肿未复发,无需进一步治疗。此外,未观察到FAc植入物向前移位或眼压升高。该手术有效减轻了这些患者的治疗负担。尽管在少数患者系列中已描述了FAc植入物的巩膜固定且结果成功,但这种方法仍属于未获批准的使用。尽管未获批准,但FAc植入物的ITC可能为那些否则将得不到治疗的患者提供一种有前景的治疗选择。